Avery Therapeutics Hires Senior Product Development Engineer

Avery Therapeutics, Inc., a cardiovascular regenerative medicine company, has named Carlos Chang senior product development engineer. Chang brings extensive experience with designing and developing biomanufacturing systems, models and products for research and medical use. The position brings Chang back to Tucson where he earned his Ph.D. in biomedical engineering at the University of Arizona.

Read More
Avery Therapeutics Featured in BizTucson Magazine Spring 2020

"The resources are here, our technology is made here, we have great power sources and we believe we're starting to put Tucson on the map." -Jordan Lancaster, CEO of Avery Therapeutics

Read More
Four UArizona Inventors Named Senior Members of National Academy of Inventors

Jordan Lancaster, assistant research scientist with the Sarver Heart Center and founder of Avery Therapeutics, which aims to advance tissue-engineered therapeutics to treat heart disease and muscle injuries. He holds three U.S. patents. Lancaster's technologies include MyCardia, which is designed to make new blood vessels and "re-muscularize" the heart, making it perform better.

Read More
Avery Therapeutics Hires Crosby as Clinical Specialist

Jessi Crosby joined Avery Therapeutics, Inc., as a clinical specialist. Crosby is responsible for leading clinical planning and operational activities to bring Avery products to patients in need. She has previous industry experience with Class 3 cardiovascular medical devices and clinical experience working with patients requiring mechanical circulatory support. Avery Therapeutics is a cardiovascular regenerative medicine company.

Read More
Natia Bamidele joins Biotech Startup Avery Therapeutics as Executive Assistant

Natia Bamidele joins biotech startup Avery Therapeutics, Inc. as Executive Assistant. Bamidele has a background in executive support, most recently at private equity firm TPG Capital in San Francisco. She earned a B.A. in psychology at the University of Nevada, Las Vegas.

Read More
Avery Therapeutics Awarded Product Assistance for Cellular Therapy grant from the NIH

Avery Therapeutics Awarded Product Assistance for Cellular Therapy Grant from the NIH titled, Development and Assesement of an Engineered Cardiac Tissue for Treating Dilated Cardiomyopathy.

Read More
Avery Therapeutics, Inc. Accepted to the Flinn Foundation Bioscience Entrepreneurship Program

Avery Therapeutics, Inc., today announced that it has been accepted to the Flinn Foundation Bioscience Entrepreneurship program. As part of the program Avery will receive $30,000 in funding and program services administered through a nonprofit partner.

Read More
Arizona Originals Podcast featuring Jordan Lancaster

This week our guest is Jordan Lancaster - the co-founder and Chief Scientific Officer of Avery Therapeutics, a Tucson-based company working to solve the problem of heart tissue regeneration. Jordan comes from a long line of cardiologists and finds himself focused on the research side of the heart…and now is leading an entrepreneurial endeavor to bring scientific innovations to make the next leap forward in cardiac care.

Read More
Avery Therapeutics, Inc. to present at the Biotech Showcase™ Annual Conference on January 8, 2018.

Avery Therapeutics, Inc., today announced that it will present at Biotech Showcase™ 2018, to be help January 8-10 during the most important week in healthcare at the Hilton San Francisco Union Square.

Read More
Avery Therapeutics to be honored with an AZBio Fast Lane Award

Arizona life science and business leaders as well as guests from across the country will be on hand to applaud the Avery Therapeutics team for their progress in developing a novel lifesaving medical device to address heart failure.

Read More